Activity Overview
This educational activity is an archive of the live presentations held at the 43rd Annual Miami Breast Cancer Conference® on March 5-8, 2026.
For more information about this educational activity, the faculty, and disclosures, please click here.
Target Audience
This educational program is directed toward medical, radiation, and surgical oncologists whose primary practice focus is breast cancer and who intend to reinforce their knowledge base and expand their expertise in breast cancer diagnosis, treatment, and management.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Incorporate the latest best practices for genomic and molecular testing to optimize risk stratification and timely identification of actionable alterations in patients with breast cancer
- Apply recent innovations in imaging modalities alongside new surgical approaches and radiation therapy techniques to improve the locoregional management of patients with breast cancer
- Evaluate the clinical implications of key findings from recent pivotal trials across early-stage and metastatic breast cancers
- Develop individualized treatment plans for patients with breast cancer based on the latest clinical data and expert guidance
- Implement supportive care strategies for preventing, mitigating, and managing treatment-related adverse events in patients receiving novel therapies for breast cancer
Patrick I. Borgen, MD
Chair, Department of Surgery
Director, Brooklyn Breast Cancer Program
Maimonides Medical Center
Brooklyn, NY
Reshma Jagsi, MD, DPhil
Lawrence W. Davis Professor
Chair, Department of Radiation Oncology
Emory University School of Medicine
Atlanta, GA
Hope S. Rugo, MD, FASCO
Director, Women’s Cancers Program
Division Chief, Breast Medical Oncology
Professor, Department of Medical
Oncology & Therapeutics Research
City of Hope Comprehensive Cancer Center
Duarte, CA
Professor Emeritus, UCSF
Full faculty information and disclosures are available by reviewing the program workbook, linked here.
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.